SP
Supernus Pharmaceuticals Inc
🇺🇸XNAS.SUPNUnited StatesHealthcare
$41.13USDdown -0.16 (-0.39%)OpenDelayed5:05 PM
Price$41.13-0.16 (-0.39%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US8684591089
- CUSIP
- 868459108
Company
- Employees
- 778
- Headquarters
- Rockville, United States
- Website
- https://www.supernus.com
- CEO
- Mr. Jack A. Khattar M.B.A.
Market
- Shares outstanding
- 58.1M
- Market cap
- $2.39B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $2.38B
- EPS LTM
- -$1.89calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -21.76calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $830.44M+24.85%up year on year
- Net income
- -$109.89M-270.37%down year on year
- Gross margin
- 88.07%-0.52%down year on year
- Free cash flow
- $18.79M-89.89%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.